How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers

Pharmacoepidemiology and Drug Safety

Volumn 11, Issue 1, 2002, Pages 37-44

  Fleuranceau Morel, P ^a  

^a Schering SA   (France)

Author keywords

ADR report handling; Consumer ADR reporting; Drug safety; Drug safety surveillance; e mail ADR reporting; Telephone call centres

Indexed keywords

DRUG;

ARTICLE; CONSUMER; CONTROLLED STUDY; DATA BASE; DOCTOR PATIENT RELATION; DRUG INDUSTRY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; E-MAIL; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; INTERPERSONAL COMMUNICATION; MANAGER; MEDICAL INFORMATION SYSTEM; MEDICAL SPECIALIST; PRIORITY JOURNAL; QUESTIONNAIRE; TELEPHONE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DRUG INDUSTRY; ELECTRONIC MAIL; FRANCE; HOTLINES; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING; QUESTIONNAIRES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0036204139     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.650     Document Type: Article

References (10)

1. Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989-1998)
2. Hepatitis B vaccination and the risk of multiple sclerosis
3. The importance of list size and consultation length as factors in general practice
4. MEDWATCH effect-a pharmaceutical company prospective
5. Adverse Drug Reactions: Can consumers provide early warning?
6. Postmarketing surveillance: Accuracy of patient drug attribution judgments
7. Monitoring by voluntary reporting at national level
8. Underreporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system
9. Who cares about pharmacovigilance?
10. Coming full circle in pharmacovigilance: Communicating safety information to patients through patient package inserts